ADX-71149

N/A

Report date: 2026/05/21 20:00:22
NME

Base Information

Drug NameADX-71149
Drug Alias NameJNJ-40411813ADX-71149JNJ-mGluR2-PAMJNJ-1813
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 modulators
TargetsMetabotropic glutamate receptor 2
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorSeizures +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaUnited States +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesJanssen Pharmaceutical KkJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsSeizures
Inactive IndicationsSchizophreniaDepressive Disorder, MajorPerceptual Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia